Saturday, October 31, 2026

Will the Clarity Act Protect Blockchain Developers? Key Insights on BRCA Amendments

Senator Wyden advocates for blockchain developer protections in the Clarity Act, balancing innovation and law enforcement needs.

BLACKPINK’s ‘GO’ Enters Billboard Hot 100 at No. 63, Sets Record for Most Entries by K-Pop Female Artist

BLACKPINK sets new K-pop records on Billboard and U.K. charts with "GO" and "DEADLINE," achieving historic sales and entries.

TJWG says North Korea’s execution system amounts to crimes against humanity, urges international pressure

TJWG highlighted North Korea's capital punishment at the World Congress, urging international pressure and emphasizing human rights violations.

News1

Author's Latest

Samsung Display Develops World’s First 2K, 165Hz Smartphone OLED, Cuts Power Consumption 30%

Samsung Display has developed the world's first smartphone OLED combining 2K resolution and a 165Hz refresh rate while cutting display power consumption by about 30%.

LG Display Expands AI Training Program to Help Non-Coders Solve Work Problems

LG Display is expanding its AX Squad to help non-developers use AI and vibe coding to automate tasks and solve real-world workplace problems across the company.

StarCraft, the Game That Fueled South Korea’s PC Bang Boom, Returns as a Shooter in 2030

Blizzard unveiled a new StarCraft open-world shooter for 2030 along with Diablo V and World of Warcraft: Forever at BlizzCon 2026.

SEERS Joins KRX Healthcare Index: What This Means for AI in Medicine

Wearable AI diagnostics firm Cears has been newly included in the KRX Healthcare Index effective from September 11.

Why Tergase is the Best Biotechnology Product of 2026: A Deep Dive into Its Innovations

Alteogen's Terghaz was awarded Best Biotechnology Product at the 2026 Prigalien Korea Awards for its recombinant human hyaluronidase.

Navigating FDA Challenges: How SK Biopharmaceuticals Plans to Move Forward with Opacalim

SK Biopharm will maintain its development and commercialization plans for epilepsy drug candidate Opacalim despite FDA's partial clinical hold.

Yuhan’s Leclaza Wins Best Pharmaceutical Product at Asia’s First Prix Galien Awards

Yuhan Corporation's lung cancer drug 'Lecanza' wins Best Pharmaceutical Product at the inaugural 'Prix Galien' in Asia.

Unlocking Cancer Treatment: How Lunit and 10x Genomics Are Pioneering New Biomarkers for Precision Medicine

Lunit partners with 10x Genomics to discover biomarkers predicting cancer drug effectiveness in patients.

How Huons Global is Transforming the Middle East Aesthetic Market with Innovative Products

Huons Group targets the Middle East market by consolidating its aesthetic products, including fillers and botulinum toxin.

Wontech Partners With China’s Yestar to Expand Medical Aesthetics Push

Wontech is partnering with Chinese medical aesthetics group Yestar to expand physician training, clinical collaboration and adoption of its NMPA-approved laser devices in China.

Vuno to Discuss AI for Pediatric Patient Safety at Global Symposium

Vuno will bring domestic and international experts together in Seoul to discuss AI-based early warning and rapid response systems for improving pediatric patient safety.

GC Pharma Wins Approval for Phase 2 Trial of COVID-19 mRNA Vaccine

GC Pharma has received approval for a Phase 2 trial of its COVID-19 mRNA vaccine candidate GC4006A and plans to advance toward Phase 3 while expanding the platform into other disease areas.

RF Bio Earns International Occupational Safety Certification, Strengthening Manufacturing Competitiveness

RF Bio has earned ISO 45001 certification as it strengthens workplace safety and manufacturing quality while expanding its medical aesthetics business globally.

SK Biopharm’s Epilepsy Drug Trial Partially Halted in U.S., New Enrollment Suspended

SK Biopharm's U.S. trials of epilepsy drug candidate opicopalim have been partially placed on hold by the FDA, temporarily stopping new enrollment while existing patients continue treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.